|
Market Closed -
NYSE
00:00:03 11/07/2026 +04
|
5-day change
|
1st Jan Change
|
|
71.66 USD
|
+0.99%
|
|
+0.48%
|
+11.34%
|
|
06-16 |
W. P. Carey Portfolio Better Positioned for Inflationary Environment, BofA Says
|
MT
| |
06-16 |
BofA Securities Upgrades W. P. Carey to Neutral From Underperform, Price Target is $83
|
MT
| |
04-30 |
RBC Lifts Price Target on W. P. Carey to $73 From $72, Keeps Sector Perform Rating
|
MT
| |
03-17 |
Raymond James Upgrades W. P. Carey to Outperform From Market Perform, Price Target is $76
|
MT
| |
03-09 |
UBS Adjusts Price Target on W. P. Carey to $75 From $68, Maintains Neutral Rating
|
MT
| |
02-12 |
RBC Lifts Price Target on W.P. Carey to $72 From $70, Keeps Sector Perform Rating
|
MT
| |
01-08 |
W. P. Carey Sees Strong Q4 Investment, Dispositions as Equity Largely Secured for 2026, RBC Says
|
MT
| |
01-08 |
RBC Lifts Price Target on W.P. Carey to $70 From $69, Keeps Sector Perform Rating
|
MT
| |
12-08 |
W. P. Carey's Growth Drivers to Have Smaller Impact in 2026, Equity Issuance a Risk, RBC Says
|
MT
| |
12-08 |
RBC Downgrades W.P. Carey to Sector Perform From Outperform, Keeps $69 Price Target
|
MT
| |
11/09/25 |
W. P. Carey Shares Rise After Wells Fargo Upgrade
|
MT
| |
11/09/25 |
Wells Fargo Upgrades W. P. Carey to Overweight From Equalweight
|
MT
| |
15/08/25 |
UBS Raises Price Target on W. P. Carey to $68 From $63, Maintains Neutral Rating
|
MT
| |
09/06/25 |
BNP Paribas Exane Upgrades W. P. Carey to Neutral From Underperform
|
MT
| |
09/06/25 |
BNP Paribas Exane Upgrades W. P. Carey to Neutral From Underperform, Adjusts PT to $66 From $63
|
MT
| |
13/05/25 |
UBS Adjusts Price Target on W. P. Carey to $63 From $66, Maintains Neutral Rating
|
MT
| |
01/05/25 |
RBC Raises Price Target on W.P. Carey to $66 From $62, Keeps Outperform Rating
|
MT
| |
18/02/25 |
BMO Capital Upgrades W. P. Carey to Outperform From Market Perform Perform, Adjusts Price Target to $67 From $60
|
MT
| |
13/02/25 |
RBC Raises Price Target on W.P. Carey to $62 From $61, Keeps Outperform Rating
|
MT
| |
06/01/25 |
UBS Adjusts Price Target on W. P. Carey to $58 From $60, Keeps Neutral Rating
|
MT
| |
12/12/24 |
RBC Trims Price Target on W.P. Carey to $62 From $63, Keeps Outperform Rating
|
MT
| |
14/11/24 |
UBS Lowers W. P. Carey Price Target to $60 From $62, Maintains Neutral Rating
|
MT
| |
16/10/24 |
UBS Adjusts Price Target on W. P. Carey to $62 From $61, Maintains Neutral Rating
|
MT
| |
30/09/24 |
RBC Raises Price Target on W. P. Carey to $67 From $62, Keeps Outperform Rating
|
MT
| |
28/08/24 |
Evercore ISI Raises Price Target on W. P. Carey to $63 From $61, Maintains In Line Rating
|
MT
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|